APA (7th ed.) Citation

Kawczak, P., & Bączek, T. (2026). Molecular Targeting of EGFR, BRAF, and HER2 Signaling in Colorectal Cancer: Contemporary Advances with Panitumumab, Encorafenib, and Tucatinib. Journal of Clinical Medicine, 15(6), 2387. https://doi.org/10.3390/jcm15062387

Chicago Style (17th ed.) Citation

Kawczak, Piotr, and Tomasz Bączek. "Molecular Targeting of EGFR, BRAF, and HER2 Signaling in Colorectal Cancer: Contemporary Advances with Panitumumab, Encorafenib, and Tucatinib." Journal of Clinical Medicine 15, no. 6 (2026): 2387. https://doi.org/10.3390/jcm15062387.

MLA (9th ed.) Citation

Kawczak, Piotr, and Tomasz Bączek. "Molecular Targeting of EGFR, BRAF, and HER2 Signaling in Colorectal Cancer: Contemporary Advances with Panitumumab, Encorafenib, and Tucatinib." Journal of Clinical Medicine, vol. 15, no. 6, 2026, p. 2387, https://doi.org/10.3390/jcm15062387.